While each country has a different priority when it comes to type 1 diabetes (T1D) diagnosis and treatment, there is a fairly consistent outcomes checklist across nations, said Tom Robinson, vice president of global access at JDRF.
The Type 1 Diabetes (T1D) Index identifies 4 key interventions: timely diagnosis, insulin and strips, pumps and CGMs, and prevention and cures. Tom Robinson, vice president of global access at JDRF, goes over what steps need to be taken to implement these interventions.
Transcript
What steps need to be taken to implement the 4 key interventions identified in the T1D Index?
The priority is going to be different every country and every health system, which is a bit of a disappointing answer, but there's kind of a consistent outcomes checklist. Can we be confident that our emergency departments diagnose type 1 [diabetes] in time? That's the core of the time of diagnosis thing. Have insulin and strips been made consistently available and affordable so that people can use them? Have we looked at funding or at least subsidizing more advanced devices? Do people get coaching and support to use all of these tools effectively? Those are questions that we can ask in every country. The question then becomes, "Okay, well, which of those is most important here?" In some places it'll be, "We've got to go and intervene with the emergency department."
The example of Santé Diabète in Mali is incredible, where they went and did some training and put up posters and distributed BGMs [blood glucose meters]. The number of diagnoses almost doubled in the next few months, and certainly a year later, there were twice as many per year. Quite an extraordinary result.
But those sorts of interventions, we've seen examples of them for all 4. There are some really great impact stories on the T1D Index website, you can go and read about people who've been able to make that change happen in their country. But you really need to kind of get into the country and listen to the people there and talk to them there to figure out, "Hey, what is the 1 thing I need to do to make this thing work?"
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More